ScholarIQanswers from OpenAlex & ORCID
Ka‐Fai To
ResearcherPublications, citations & collaboration network
Ka‐Fai To is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Ka‐Fai To have?
ScholarIQindexed works
Ka‐Fai To has 1,086 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Ka‐Fai To have?
ScholarIQcitation count
Ka‐Fai To has 50,466 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Ka‐Fai To?
ScholarIQh-index
Ka‐Fai To has an h-index of 120 in OpenAlex.
What is the i10-index of Ka‐Fai To?
ScholarIQi10-index
Ka‐Fai To has an i10-index of 494 in OpenAlex.
What is the ORCID of Ka‐Fai To?
ScholarIQorcid
The ORCID for Ka‐Fai To is on the source record.
What is the OpenAlex record for Ka‐Fai To?
ScholarIQopenalex
The OpenAlex for Ka‐Fai To is on the source record.
What are the most-cited papers on Ka‐Fai To?
ScholarIQmost cited works
A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong
Nelson Lee, David S.C. Hui, Alan Wu, Paul K.S. Chan, Peter Cameron, Gavin M. Joynt, Anil T. Ahuja, Man Yee Yung, C. B. Leung, Ka‐Fai To, Siu Fai Lui, Cheuk‐Chun Szeto, Sydney Chung, Joseph J.�Y. Sung
Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)
Masahiro Fukuoka, Yi‐Long Wu, Sumitra Thongprasert, Patrapim Sunpaweravong, Swan-Swan Leong, Virote Sriuranpong, Tsu-Yi Chao, Kazuhiko Nakagawa, Da-Tong Chu, Nagahiro Saijo, Emma Duffield, Yuri Rukazenkov, Georgina Speake, Haiyi Jiang, Alison Armour, Ka‐Fai To, James Chih‐Hsin Yang, Tony Mok
Acute renal impairment in coronavirus-associated severe acute respiratory syndrome
Kwok Hong Chu, Wai Kay Tsang, Colin Tang, Man Fai Lam, Fernand M.M. Lai, Ka‐Fai To, Samuel Fung, Hon Lok Tang, Wing‐Wa Yan, Hilda Chan, Thomas S. T. Lai, Kwok Lung Tong, Kar Neng Lai
Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
Brigette Ma, Wan‐Teck Lim, Boon Cher Goh, Edwin P. Hui, Kwok Wai Lo, Adam Pettinger, Nathan R. Foster, Jonathan W. Riess, Mark Agulnik, Alex Y. Chang, Akhil Chopra, Julie A. Kish, Christine H. Chung, Douglas R. Adkins, Kevin J. Cullen, Barbara J. Gitlitz, Dean Lim, Ka‐Fai To, K.C. Allen Chan, Yuk Ming Dennis Lo, Ann D. King, Charles Erlichman, Jun Yin, Brian A. Costello, Anthony T.�C. Chan
Atrophy and intestinal metaplasia one year after cure of H. pylori infection: A prospective, randomized study
Joseph J.�Y. Sung, San–Rin Lin, Jessica Y. L. Ching, Li–Ya Zhou, Ka‐Fai To, Ren–Ten Wang, Wai K. Leung, Enders K. Ng, James Lau, Yuk T. Lee, Chung Kwong Yeung, William Chao, S. C. S. Chung